logo

For the Inventor, By the Inventor

Martinsville, IN, United States of America

Karen L Cox

This inventor holds 8 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 1989-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karen L Cox. Retrieved from https://idiyas.com/inventor/karen-l-cox

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 5

Forward Citations = 88(Granted Patents)


Company Filing History:

goldMedal8 out of 4,509 
 
Eli Lilly and Company
 patents

Years Active: 1989-2022

Loading Chart...
8 patents (USPTO):Explore Patents
1. 11267882 - Methods of detecting human IL-21 (2022-03-08),
2. 5672497 - Method for increasing the antibiotic-producing ability of (1997-09-30),
3. 5190871 - Use of the site-specific integrating function of phage .phi.C31 (1993-03-02),
4. 5168052 - Method for producing 20-deoxotylosin (1992-12-01),
5. 5149638 - Tylosin biosynthetic genes tylA, tylB and tylI (1992-09-22),
6. 5098837 - Macrolide biosynthetic genes for use in streptomyces and other organisms (1992-03-24),
7. 5063155 - Method for producing 2''-O-demethyltylosin (1991-11-05),
8. 4889809 - Tylosin resistance-conferring gene, designated tlrC, for use in (1989-12-26),

Title: The Innovative Contributions of Karen L. Cox

Introduction

Karen L. Cox is a prominent inventor based in Martinsville, IN (US). She has made significant contributions to the field of biotechnology, particularly in the development of methods and tools for detecting and enhancing antibiotic production. With a total of 8 patents to her name, her work has had a substantial impact on medical diagnostics and microbial biotechnology.

Latest Patents

Among her latest patents is a method for detecting human IL-21. This invention provides antibodies that bind to human IL-21, which are useful in various immunoassays and imaging methods. These antibodies play a crucial role in determining IL-21 levels for diagnostic and therapeutic purposes. Another notable patent involves a method for increasing the antibiotic-producing ability of microbial host cells. This method includes transforming antibiotic-producing microorganisms with recombinant DNA vectors that enhance the expression of key biosynthetic enzymes, thereby improving antibiotic production.

Career Highlights

Karen L. Cox is currently associated with Eli Lilly and Company, where she continues to innovate and contribute to advancements in biotechnology. Her work has not only advanced scientific understanding but has also paved the way for new therapeutic strategies in treating diseases.

Collaborations

Throughout her career, Karen has collaborated with esteemed colleagues such as Eugene T. Seno and Robert J. Beckmann. These collaborations have further enriched her research and expanded the impact of her inventions.

Conclusion

Karen L. Cox exemplifies the spirit of innovation in biotechnology through her patents and contributions to antibiotic production and medical diagnostics. Her work continues to influence the field and improve health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…